A Comparative Study of New Medications for Psychosis in Adolescents

Completed · Not applicable

Conditions studied: Psychotic Disorders, Schizophrenia, Schizophreniform Disorders, Schizoaffective Disorders

In brief

The overall goal of this study is to determine the efficacy and tolerability of three atypical antipsychotic medications (risperidone, olanzapine, and quetiapine) in the treatment of adolescents with psychosis. It is hypothesized that the three medications will be equally effective in reducing the symptoms of psychosis.

Key facts

Study ID
NCT00222495
Run by
University of Minnesota
People needed
30
Starts
2002-08-01
Expected to finish
2006-08-01
Last updated by the study team
2006-09-11

Who can join

Age: 12 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.